Source: HydrUstent  Jul 03, 2018
Stents are widely used in patient care, but a major complication is infection and, for many types of stents, the need for eventual surgical removal. HydrUStent, a startup based at the University of Minho in Portugal, hopes to improve those limitations.   HydrUStent’s product is a ureteral stent made from a patented material that is antibacterial, homogeneous, and biodegradable. I...
Staff Writer, TMN  Jul 04, 2018
The US Food and Drug Administration (FDA) has approved updated labeling for Keytruda (pembrolizumab; Merck) and Tecentriq (atezolizumab; Genentech) for patients with locally advanced or metastatic urothelial cancer who are not eligible for cisplatin-containing chemotherapy. The  USFDA is continuing to review Merck's Keytruda and Roche's Tecentriq in pr...
Staff Writer, TMN  Jul 12, 2018
Scientists on the hunt for anti-aging drugs say they've made an advance with tantalizing potential: Two experimental drugs appear to safely boost the immune systems of elderly humans. The researchers stress that more research is needed to confirm the findings and show the drugs are safe. And at least one researcher says the findings are based on a relatively small number of people and u...
Staff Writer, TMN  Jul 21, 2018
The use of permanent cosmetics dates back thousands of years in history. Microblading, a technique for creating natural looking eyebrows using pigment, has reemerged in popularity in the 21st century, and has rapidly become one of the most popular cosmetic procedures in the United States .However, it has not completely replaced traditional eyebrow micropigmentation techniques: Many peopl...
Presented by
Source : University of Washington Health Sciences/UW Medicine  Sep 18, 2018
Jay Shendure and Lea Starita, faculty in the Department of Genome Sciences at the University of Washington School of Medicine, are the senior authors. Shendure directs the Brotman Baty Institute for Precision Medicine in Seattle, which helped support the study. Starita co-directs the Brotman Baty Advanced Technology Lab. Shendure is also a Howard Hughes Medical Institute investigator. Greg Findla...
Source:University of California, Los Angeles  Sep 18, 2018
Scientists have long known that circulating tumor cells, rare cancer cells that are released into the bloodstream, have the potential to provide vital information about a person's specific cancer. But until now, they have been unable to reliably access information on how these cells behave. UCLA researchers have created a quick and effective mechanism to measure how these cells perform functio...
Source:University of Illinois at Chicago  Sep 18, 2018
Clinicians, scientists and public health professionals should proudly "declare victory" in their efforts to extend the human lifespan to its very limits, according to University of Illinois at Chicago epidemiologist S. Jay Olshansky. In an article published in the Journal of the American Medical Association, Olshansky writes that the focus should shift to compressing the "re...
Source: European Centre for Disease Prevention and Control (ECDC)  Sep 06, 2018
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriax...
Source: Cedars-Sinai Medical Center  Sep 06, 2018
Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostrate Cancer Prostate cancer is the second-leading cause of cancer death in men, behind lung cancer, k...